Chris Sugg

Chris Sugg is a seasoned professional in the pharmaceutical industry, specializing in US medical managed market strategy, health policy, and collaborative health outcomes projects for oncology, hematology, and rare diseases.

With a background that includes experiences at Novartis, Amgen, and GlaxoSmithKline, Chris brings a wealth of knowledge and expertise in clinical and commercial acumen, as well as global market strategies.

A graduate of the University of North Carolina at Chapel Hill, Chris has held various roles of increasing responsibility in both the US and global markets, showcasing his ability to navigate and excel in diverse environments.

His international exposure includes serving as the Director of Emerging Markets and Asia Pacific in London for GlaxoSmithKline, where he gained valuable insights into highly managed markets, payer dynamics, and the importance of reimbursement organizations.

Chris has played a pivotal role in new product strategy and biosimilar planning, contributing to optimizing payer value propositions and enhancing access to innovative therapies for patients worldwide.

A sought-after speaker, Chris has shared his expertise in numerous countries and played a part in securing regulatory approvals for therapeutics in Singapore and Malaysia, while also providing strategic guidance for health outcome programs in various regions such as the USA, China, Vietnam, and Latin America.

Currently pursuing a Master's degree in Applied Pharmacoeconomics, Health Outcomes & Health Policy at the University of Florida, Chris plans to leverage his PharmD and health economics background to continue delivering value to patients, providers, and payers.

Driven by a personal connection to oncology due to the loss of his father to lung cancer, Chris demonstrates unwavering commitment to his work. Outside of his professional endeavors, he engages in triathlons and volunteers as an AMCP Regional Diplomat.